Veradigm EBITDA 2010-2022 | MDRX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Veradigm ebitda from 2010 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Veradigm ebitda from 2010 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$46.1B
Doximity (DOCS)	$11.3B
Hims & Hers Health (HIMS)	$11.3B
Tempus AI (TEM)	$10.6B
IRhythm Technologies (IRTC)	$4.3B
Inspire Medical Systems (INSP)	$3.7B
Hinge Health (HNGE)	$3.7B
Privia Health (PRVA)	$2.4B
Schrodinger (SDGR)	$1.6B
Phreesia (PHR)	$1.5B
Enovis (ENOV)	$1.5B
Clover Health Investments (CLOV)	$1.5B
10x Genomics (TXG)	$1.5B
Azenta (AZTA)	$1.4B
Omnicell (OMCL)	$1.3B
Evolent Health (EVH)	$1.1B
Claritev (CTEV)	$702M
Fulgent Genetics (FLGT)	$541M
Standard BioTools (LAB)	$467M
Butterfly Network (BFLY)	$462M
Talkspace (TALK)	$415M
TruBridge (TBRG)	$336M
Outset Medical (OM)	$309M
Nyxoah SA (NYXH)	$280M
Health Catalyst (HCAT)	$254M
SOPHiA GENETICS SA (SOPH)	$248M
CapsoVision (CV)	$211M
Zepp Health (ZEPP)	$191M
KORU Medical Systems (KRMD)	$155M
Pulmonx (LUNG)	$127M